I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 65 filers reported holding I MAB in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $737,290 | -54.1% | 558,553 | +3.9% | 0.00% | -100.0% |
| Q2 2023 | $1,607,600 | -12.5% | 537,659 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,837,931 | -19.1% | 531,194 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $2,271,713 | +411.6% | 543,472 | +390.4% | 0.00% | – |
| Q3 2022 | $444,000 | -82.1% | 110,815 | -49.4% | 0.00% | -100.0% |
| Q2 2022 | $2,477,000 | +49.1% | 219,159 | +114.4% | 0.00% | 0.0% |
| Q1 2022 | $1,661,000 | -50.4% | 102,241 | +44.7% | 0.00% | 0.0% |
| Q4 2021 | $3,349,000 | -51.0% | 70,664 | -25.1% | 0.00% | -50.0% |
| Q3 2021 | $6,836,000 | -52.1% | 94,302 | -44.5% | 0.00% | -60.0% |
| Q2 2021 | $14,271,000 | +44496.9% | 169,994 | +25656.7% | 0.01% | – |
| Q1 2021 | $32,000 | +14.3% | 660 | +10.7% | 0.00% | – |
| Q4 2020 | $28,000 | -96.7% | 596 | -96.7% | 0.00% | – |
| Q3 2020 | $857,000 | +3196.2% | 18,224 | +818.1% | 0.00% | – |
| Q1 2020 | $26,000 | – | 1,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |